ArticleMolecular neurobiology2025
Carnosic Acid Attenuated the Motor Impairment by Bisphenol A is Related to the Regulation of Autophagy Through Parkin in In Vitro and In Vivo.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Bisphenol A (BPA) is an endocrine-disrupting compound linked to impairments in motor function and the manifestation of anxiety-like behaviors. The present study investigated the effects of carnosic acid (CA) on BPA-induced motor deficits and explored the role of parkin in the autophagic mechanism. First, C57BL/6 J male mice were orally administered with CA (5 mg/kg and 20 mg/kg) or RE (80 mg/kg rosemary extract) to test the motor function and anxiety-like behaviors in BPA (50 μg/kg) treatment. The results showed that CA and RE ameliorate BPA-induced motor impairments and anxiety-like behaviors. Moreover, CA and RE attenuated BPA-induced phosphorylation of tau and α-synuclein while restoring the expression levels of autophagy-related proteins, including parkin, PINK1, PI3K, Atg7, Beclin1, and LC3B-II. Then, SH-SY5Y cells were treated with 20 nM BPA and 1 μM CA or 0.5 μg/mL RE for 18 h. The results showed that treatment of CA and RE with BPA activated the parkin pathway and reduced the levels of
Indexed as
Identifiers
40317414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.